Cannabinoid Hyperemesis Syndrome

This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.

Authors

Thangam Venkatesan (ORCID: https://orcid.org/0000-0002-8095-7456)
Michael Camilleri
William L. Hasler

Institutions

Mayo Clinic (US)
Mayo Clinic in Arizona (US)
The Ohio State University (US)

Publication Details

Journal: JAMA
Published: 2026-08-26
DOI: https://doi.org/10.1001/jama.2026.7873
Primary Topic: Cannabis and Cannabinoid Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cannabinoid Hyperemesis Syndrome

Thangam Venkatesan, Michael Camilleri, William L. Hasler

Aug 26, 2026

JAMA

Cannabis and Cannabinoid Research

article

Cannabinoid Hyperemesis Syndrome

Thangam Venkatesan, Michael Camilleri, William L. Hasler

August 26, 2026article en

Abstract

This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.

JAMA

Mayo Clinic (US), Mayo Clinic in Arizona (US), The Ohio State University (US)

Good health and well-being

Openalex Percentile: Top 12%

Cannabis and Cannabinoid Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cannabinoid Hyperemesis Syndrome — Thangam Venkatesan, Michael Camilleri, et al. · JAMA (2026) | TGRS Research Map | TGRS